Oral News and Research

RSS

Evidence suggests that changes in the bacteria and fungi in the gastrointestinal tract can intensify the immune system's reaction to common allergens

If you want to avoid allergies or asthma, scientists at the University of Michigan Medical School suggest you start paying more attention to what's in your gut.

23 Dec 2004

Gulf War report confirms link between lung cancer and combustion products

The available evidence is too sparse or of insufficient quality to determine whether the majority of health problems that may be experienced by Gulf War veterans could be associated with exposures to fuels for military vehicles, propellents in Scud missiles, or substances given off by combustion sources such as oil-well fires, exhausts, and tent heaters

21 Dec 2004

Major step forward in using saliva to detect oral cancer

Scientists funded by the National Institute of Dental and Craniofacial Research reported taking a major step forward in using saliva to detect oral cancer.

21 Dec 2004

Messenger RNA not only are measurable in saliva but can indicate a developing tumor

Scientists funded by the National Institute of Dental and Craniofacial Research reported today taking a major step forward in using saliva to detect oral cancer.

20 Dec 2004

At-home hand dermatitis treatment with oral medication and use of a portable tanning effective treatment for hand eczema

An at-home hand dermatitis treatment with oral medication and use of a portable tanning unit appears to be as effective as a hospital-based treatment in reducing the symptoms of hand dermatitis, according to an article in the December issue of The Archives of Dermatology.

20 Dec 2004

Oral medication alitretinoin effective in treating moderate or severe hand dermatitis

Use of the oral medication alitretinoin was effective in treating moderate or severe hand dermatitis in nearly half of patients previously unresponsive to standard treatment, according to an article in the December issue of The Archives of Dermatology.

20 Dec 2004

Advice for patients who have been taking Celebrex or Bextra

The recent announcement that Celebrex, a popular pain drug in the same family as Vioxx, has been found to pose an increased risk of heart problems is bound to leave many pain patients stunned, confused and worried.

20 Dec 2004

Link between socio-economic status and tooth decay

Children attending schools classified as deprived were reported to have experienced more tooth decay than children in non-deprived schools, according to further analysis of the 2003 Children's Dental Health Survey by the Office for National Statistics.

20 Dec 2004

Benzoyl peroxide effective treatment for acne

Results of a UK study in this week’s issue of THE LANCET highlight how over the counter benzoyl peroxide (BEN-zoe-ill per-OX-ide) lotion is as good as prescription antibiotics for the treatment of mild to moderate facial acne.

20 Dec 2004

Landmark studies that may change the treatment standards for breast cancer

The 27th Annual San Antonio Breast Cancer Symposium that took place December 8-11 included the presentation of several landmark studies that may change the treatment standards for breast cancer.

14 Dec 2004

Link found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw

Doctors at Long Island Jewish (LIJ) Medical Center recently discovered a link between a common chemotherapy drug and a serious bone disease called osteonecrosis of the jaw (ONJ).

13 Dec 2004

Diabetics who do not have good control over their blood sugar levels are more susceptible to oral health problems

Diabetes affects 18.2 million people in the United States and is expected to double by the year 2010. Additionally, diabetics who do not have good control over their blood sugar levels are more susceptible to oral health problems than non-diabetics

13 Dec 2004

Migraine sufferers are twice as likely to suffer a stroke than those who don't experience migraines

In the first review of its kind, researchers in Canada and the US looked at 14 studies which investigated an association between stroke and migraine. They found that the risk of stroke for migraine sufferers was 2.16 times that for non-sufferers.

13 Dec 2004

Zarnestra, a farnesyl transferase inhibitor, can help treat high-risk myelodysplastic syndrome patients

An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).

7 Dec 2004

Revlimid clinical data in newly diagnosed multiple myeloma presented

Celgene Corporation announced today that data evaluating clinical results on Revlimid (lenalidomide) as a new therapeutic approach for patients with newly diagnosed multiple myeloma (MM) was presented at the American Society of Hematology 46th Annual Meeting in San Diego.

7 Dec 2004

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

The combination of two pills -- thalidomide and dexamethasone -- may be an effective alternative to the intravenous chemotherapy commonly prescribed to patients with multiple myeloma, according to a large collaborative study conducted by the Eastern Cooperative Oncology Group and led by a Mayo Clinic investigator.

7 Dec 2004

New insight into anticoagulation therapies

Anticoagulation therapies, or treatments that reduce the amount of clotting factors in the blood, are quite common and used for a variety of reasons.

6 Dec 2004

Majority of hospitalizations for asthma may be the result of people not taking their inhaled steroid medications

Inhaled steroids have become the standard in the treatment of persistent asthma. They have been shown to significantly improve asthma symptoms and reduce asthma complications. However, adherence to the prescribed inhaled steroids is poor among adult asthma patients.

6 Dec 2004

Single dose phase I data on CG53135 for the prevention of oral mucositis

CuraGen Corporation has announced results presented from a Phase I clinical trial with CG53135 for the prevention of oral mucositis (OM) in patients receiving high dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (AHSCT) at the ASH 46th Annual Meeting in San Diego, CA.

5 Dec 2004

Oral targeted therapy shows benefit in treating high-risk myelodysplastic syndrome

4 Dec 2004

Oral News and Research

Evidence suggests that changes in the bacteria and fungi in the gastrointestinal tract can intensify the immune system's reaction to common allergens

Gulf War report confirms link between lung cancer and combustion products

Major step forward in using saliva to detect oral cancer

Messenger RNA not only are measurable in saliva but can indicate a developing tumor

At-home hand dermatitis treatment with oral medication and use of a portable tanning effective treatment for hand eczema

Oral medication alitretinoin effective in treating moderate or severe hand dermatitis

Advice for patients who have been taking Celebrex or Bextra

Link between socio-economic status and tooth decay

Benzoyl peroxide effective treatment for acne

Landmark studies that may change the treatment standards for breast cancer

Link found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw

Diabetics who do not have good control over their blood sugar levels are more susceptible to oral health problems

Migraine sufferers are twice as likely to suffer a stroke than those who don't experience migraines

Zarnestra, a farnesyl transferase inhibitor, can help treat high-risk myelodysplastic syndrome patients

Revlimid clinical data in newly diagnosed multiple myeloma presented

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

New insight into anticoagulation therapies

Majority of hospitalizations for asthma may be the result of people not taking their inhaled steroid medications

Single dose phase I data on CG53135 for the prevention of oral mucositis

Oral targeted therapy shows benefit in treating high-risk myelodysplastic syndrome

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News